2.50
Hdl Handle:
http://hdl.handle.net/2336/3026
Title:
Neurodevelopmental treatment after stroke: a comparative study
Authors:
Hafsteinsdottir, T B; Algra, A; Kappelle, L J; Grypdonck, M H F
Citation:
J. Neurol. Neurosurg. Psychiatr. 2005, 76(6):788-92
Issue Date:
1-Jun-2005
Abstract:
BACKGROUND: Neurodevelopmental treatment (NDT) is a rehabilitation approach increasingly used in the care of stroke patients, although no evidence has been provided for its efficacy. OBJECTIVE: To investigate the effects of NDT on the functional status and quality of life (QoL) of patients with stroke during one year after stroke onset. METHODS: 324 consecutive patients with stroke from 12 Dutch hospitals were included in a prospective, non-randomised, parallel group study. In the experimental group (n = 223), nurses and physiotherapists from six neurological wards used the NDT approach, while conventional treatment was used in six control wards (n = 101). Functional status was assessed by the Barthel index. Primary outcome was "poor outcome", defined as Barthel index <12 or death after one year. QoL was assessed with the 30 item version of the sickness impact profile (SA-SIP30) and the visual analogue scale. RESULTS: At 12 months, 59 patients (27%) in the NDT group and 24 (24%) in the non-NDT group had poor outcome (corresponding adjusted odds ratio = 1.7 (95% confidence interval, 0.8 to 3.5)). At discharge the adjusted odds ratio was 0.8 (0.4 to 1.5) and after six months it was 1.6 (0.8 to 3.2). Adjusted mean differences in the two QoL measures showed no significant differences between the study groups at six or 12 months after stroke onset. CONCLUSIONS: The NDT approach was not found effective in the care of stroke patients in the hospital setting. Health care professionals need to reconsider the use of this approach.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://jnnp.bmjjournals.com/cgi/content/full/76/6/788

Full metadata record

DC FieldValue Language
dc.contributor.authorHafsteinsdottir, T B-
dc.contributor.authorAlgra, A-
dc.contributor.authorKappelle, L J-
dc.contributor.authorGrypdonck, M H F-
dc.date.accessioned2006-06-07T16:33:41Z-
dc.date.available2006-06-07T16:33:41Z-
dc.date.issued2005-06-01-
dc.identifier.citationJ. Neurol. Neurosurg. Psychiatr. 2005, 76(6):788-92en
dc.identifier.issn0022-3050-
dc.identifier.pmid15897499-
dc.identifier.doi10.1136/jnnp.2004.042267-
dc.identifier.urihttp://hdl.handle.net/2336/3026-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractBACKGROUND: Neurodevelopmental treatment (NDT) is a rehabilitation approach increasingly used in the care of stroke patients, although no evidence has been provided for its efficacy. OBJECTIVE: To investigate the effects of NDT on the functional status and quality of life (QoL) of patients with stroke during one year after stroke onset. METHODS: 324 consecutive patients with stroke from 12 Dutch hospitals were included in a prospective, non-randomised, parallel group study. In the experimental group (n = 223), nurses and physiotherapists from six neurological wards used the NDT approach, while conventional treatment was used in six control wards (n = 101). Functional status was assessed by the Barthel index. Primary outcome was "poor outcome", defined as Barthel index <12 or death after one year. QoL was assessed with the 30 item version of the sickness impact profile (SA-SIP30) and the visual analogue scale. RESULTS: At 12 months, 59 patients (27%) in the NDT group and 24 (24%) in the non-NDT group had poor outcome (corresponding adjusted odds ratio = 1.7 (95% confidence interval, 0.8 to 3.5)). At discharge the adjusted odds ratio was 0.8 (0.4 to 1.5) and after six months it was 1.6 (0.8 to 3.2). Adjusted mean differences in the two QoL measures showed no significant differences between the study groups at six or 12 months after stroke onset. CONCLUSIONS: The NDT approach was not found effective in the care of stroke patients in the hospital setting. Health care professionals need to reconsider the use of this approach.en
dc.language.isoenen
dc.publisherBMJ Publishing Groupen
dc.relation.urlhttp://jnnp.bmjjournals.com/cgi/content/full/76/6/788en
dc.subjectCerebrovascular Accidenten
dc.subjectQuality of Lifeen
dc.subjectSickness Impact Profileen
dc.subjectCognition Disordersen
dc.subjectNeuropsychological Testsen
dc.subjectSeverity of Illness Indexen
dc.subjectTreatment Outcomeen
dc.subjectLength of Stayen
dc.subjectMaleen
dc.subjectFemaleen
dc.subjectAgeden
dc.subjectComparative Studyen
dc.subjectHospitalizationen
dc.subjectProspective Studiesen
dc.subjectQuestionnairesen
dc.subjectResearch Support, Non-U.S. Gov'ten
dc.titleNeurodevelopmental treatment after stroke: a comparative studyen
dc.typeArticleen
dc.format.digYES-

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.